Showing results (861-870 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|May 25, 2004
Clinical pharmacology: special safety considerations in drug development and pharmacovigilanceKwame N Atuah, Dyfrig Hughes, Munir Pirmohamed
Drug Safety|May 25, 2004
Current requirements and emerging trends for labelling as a tool for communicating pharmacovigilance findingsA Leander Fontaine
Drug Safety|May 25, 2004
Crisis management strategiesMaria C Koster, Helen Politis-Norton
Drug Safety|March 9, 2004
Pregnancy exposure registriesDianne L Kennedy, Kathleen Uhl, Sandra L Kweder
Drug Safety|March 9, 2004
Benefit-risk assessment of tegaserod in irritable bowel syndromeRichard Lea, Peter J Whorwell
Drug Safety|May 1, 1992
Mutagenicity of quinolone antibacterialsF L Fort
Drug Safety|May 1, 1992
Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancyP M Kyle, C W Redman
Drug Safety|January 1, 1992
Clinical experience of clozapine-induced neutropenia in the UK. Laboratory investigation using liquid culture systems and immunofluorocytometryP A Veys, S Wilkes, S Shah, et al.
Drug Safety|January 1, 1992
Possible role of free radical formation in drug-induced agranulocytosisR P Mason, V Fischer
Drug Safety|February 6, 2004
The risk of severe depression, psychosis or panic attacks with prophylactic antimalarialsChristoph R Meier, Karen Wilcock, Susan S Jick
Pageof 309